Peptides in United States
How peptides are regulated in the United States: FDA approval status, the "research chemical" grey market, compounding-pharmacy routes, and GLP-1 telehealth. Educational clarity, not a sales pitch.
The United States is the largest peptide market and the most confusing. A given peptide can be an FDA-approved medicine, a pharmacy-compounded preparation, an ingredient flagged by the FDA as presenting safety risks, or a "research chemical, not for human use" sold online. Sometimes several of these at once, depending on who is selling it.
FDA (U.S. Food and Drug Administration) regulates drugs and biologics. Approved peptide medicines (for example, certain GLP-1 receptor agonists such as semaglutide) are prescription-only and dispensed through pharmacies. Compounding pharmacies may prepare some peptides under specific conditions, and those conditions change: the FDA periodically revises which substances may be compounded under sections 503A and 503B.
Much of what is sold online as a peptide is labeled "for research use only." That label does not make human use legal or safe; it is how sellers attempt to sidestep medicines regulation. We describe this reality plainly so readers can tell an approved medicine apart from a grey-market product.
This page is an overview. For any specific compound, see its country page below, and always verify the current status with the FDA before acting.
Importation
The FDA and U.S. Customs and Border Protection can refuse or detain imports of unapproved drugs. A narrow personal-importation discretion exists in limited circumstances, but it is not a general permission to import unapproved peptides. Treat online "research chemical" imports as legally risky.
Personal possession
Personal possession of an approved, lawfully prescribed peptide medicine is ordinary. Possession of unapproved "research" peptides sits in a grey area: it is not a controlled-substance offence for most peptides, but it is not endorsed either, and supply for human use is what regulators target.
Penalties for sale
Selling or supplying unauthorised medicines, or supplying prescription-only medicines without authorisation, is an offence. FDA (U.S. Food and Drug Administration) sets out the applicable sanctions; we deliberately do not reproduce specific figures here because they change. Confirm the current penalties with the regulator.